Search Results - "Argerich, Josep"
-
1
Disease-modifying effects of natural Δ9-tetrahydrocannabinol in endometriosis-associated pain
Published in eLife (01-01-2020)“…Endometriosis is a chronic painful disease highly prevalent in women that is defined by growth of endometrial tissue outside the uterine cavity and lacks…”
Get full text
Journal Article -
2
Unique effect of clozapine on adenosine A2A-dopamine D2 receptor heteromerization
Published in Biomedicine & pharmacotherapy (01-04-2023)“…The striatal dopamine D2 receptor (D2R) is generally accepted to be involved in positive symptoms of schizophrenia and is a main target for clinically used…”
Get full text
Journal Article -
3
The ADORA1 mutation linked to early-onset Parkinson’s disease alters adenosine A1-A2A receptor heteromer formation and function
Published in Biomedicine & pharmacotherapy (01-12-2022)“…Adenosine modulates neurotransmission through inhibitory adenosine A1 receptors (A1Rs) and stimulatory A2A receptors (A2ARs). These G protein-coupled receptors…”
Get full text
Journal Article -
4
SERVICE-LEARNING IN NEUROSCIENCE TEACHING AND DISSEMINATION OF RESEARCH
Published in IBRO neuroscience reports (01-10-2023)Get full text
Journal Article -
5
Design, Synthesis and Characterization of a New Series of Fluorescent Metabotropic Glutamate Receptor Type 5 Negative Allosteric Modulators
Published in Molecules (Basel, Switzerland) (27-03-2020)“…In recent years, new drug discovery approaches based on novel pharmacological concepts have emerged. Allosteric modulators, for example, target receptors at…”
Get full text
Journal Article -
6
Ecto-GPR37: a potential biomarker for Parkinson's disease
Published in Translational neurodegeneration (26-02-2021)“…α-Synuclein has been studied as a potential biomarker for Parkinson's disease (PD) with no concluding results. Accordingly, there is an urgent need to find out…”
Get full text
Journal Article -
7
GPR37 processing in neurodegeneration: a potential marker for Parkinson’s Disease progression rate
Published in NPJ Parkinson's Disease (10-09-2024)“…The orphan G protein-coupled receptor 37 (GPR37), widely associated with Parkinson’s disease (PD), undergoes proteolytic processing under physiological…”
Get full text
Journal Article -
8
Unique effect of clozapine on adenosine A 2A -dopamine D 2 receptor heteromerization
Published in Biomedicine & pharmacotherapy (01-04-2023)“…The striatal dopamine D receptor (D R) is generally accepted to be involved in positive symptoms of schizophrenia and is a main target for clinically used…”
Get full text
Journal Article -
9
GPR37 is processed in the N‐terminal ectodomain by ADAM10 and furin
Published in The FASEB journal (01-06-2021)“…GPR37 is an orphan G protein‐coupled receptor (GPCR) implicated in several neurological diseases and important physiological pathways in the brain. We…”
Get full text
Journal Article -
10
Cannabidiol negatively modulates adenosine A 2A receptor functioning in living cells
Published in Acta neuropsychiatrica (01-10-2024)“…Cannabidiol (CBD) is a phytocannabinoid with great potential in clinical applications. The mechanism(s) of action of CBD require further investigation…”
Get more information
Journal Article -
11
B2R-D2R Interaction in Prolactinomas and Nonfunctional Adenomas: Impact on Dopamine Resistance
Published in Endocrinology (Philadelphia) (30-10-2024)“…Abstract Prolactinomas, the most common pituitary-secreting adenomas, can be effectively treated with dopamine D2 receptor (D2R) agonists. However, a subset of…”
Get full text
Journal Article